This hypothesis is further strengthened by other groups who observed increased leptin levels in NSCLC patients and recognized leptin as a risk factor for cancer, even after controlling for BMI and recent weight loss [139]. This evidence concerns the gene LEP and non-small cell lung carcinoma.